EXTENET Trademark

Trademark Overview

On Wednesday, May 6, 2009, a trademark application was filed for EXTENET with the United States Patent and Trademark Office. The USPTO has given the EXTENET trademark a serial number of 77730577. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 7, 2017. This trademark is owned by WYETH. The EXTENET trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical studies relating to oncology pharmaceutical preparations for human use
extenet

General Information

Serial Number77730577
Word MarkEXTENET
Filing DateWednesday, May 6, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 7, 2017
Registration Number3832794
Registration DateTuesday, August 10, 2010
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 15, 2009

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of uppercase "E" lowercase "x t e" uppercase "N E T".
Goods and ServicesMedical and scientific research, namely, conducting clinical studies relating to oncology pharmaceutical preparations for human use
Pseudo MarkEXTE NET

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 7, 2017
Primary Code042
First Use Anywhere DateTuesday, June 30, 2009
First Use In Commerce DateTuesday, June 30, 2009

Trademark Owner History

Party NameWYETH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NameWYETH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMADISON, NJ 07940
Party NameWYETH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMADISON, NJ 07940

Trademark Events

Event DateEvent Description
Friday, April 7, 2017CANCELLED SEC. 8 (6-YR)
Monday, August 10, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, January 6, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 6, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 23, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 20, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 10, 2010REGISTERED-PRINCIPAL REGISTER
Friday, July 9, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 8, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, July 6, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 1, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 30, 2010STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 3, 2010USE AMENDMENT FILED
Wednesday, June 30, 2010EXTENSION 1 GRANTED
Monday, June 7, 2010EXTENSION 1 FILED
Tuesday, June 29, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 7, 2010TEAS STATEMENT OF USE RECEIVED
Thursday, June 3, 2010TEAS EXTENSION RECEIVED
Tuesday, December 8, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 15, 2009PUBLISHED FOR OPPOSITION
Wednesday, August 26, 2009NOTICE OF PUBLICATION
Thursday, August 13, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 13, 2009ASSIGNED TO LIE
Wednesday, August 5, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 4, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, August 4, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 4, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, August 4, 2009EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 29, 2009ASSIGNED TO EXAMINER
Tuesday, May 12, 2009NOTICE OF PSEUDO MARK MAILED
Monday, May 11, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 9, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

extenet oncology relating pharmaceutical preparations human studies clinical scientific research namely